Table 2 Multivariable analysis of disease-free survival in patients with stage III squamous NSCLC.

From: Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer

Variable

Reference

P value

HR

95% CI

Lower

Upper

Smurf2 expression

Quartile 1

0.16

   

Quartile 2

 

0.16

2.54

0.70

9.29

Quartile 3

 

0.23

2.08

0.63

6.87

Quartile 4

 

0.02

3.77

1.21

11.80

  1. Race, T stage, and surgical margin were included in the multivariable analysis.